Eric Olson

Array ( [id] => 6551968 [patent_doc_number] => 20100222599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PROCESSES FOR THE PREPARATION OF SGLT2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/545400 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19310 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222599.pdf [firstpage_image] =>[orig_patent_app_number] => 12545400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5466015 [patent_doc_number] => 20090326215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE' [patent_app_type] => utility [patent_app_number] => 12/545175 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20605 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326215.pdf [firstpage_image] =>[orig_patent_app_number] => 12545175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628055 [patent_doc_number] => 20100004190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'BLOCKING THE MIGRATION OR METASTASIS OF CANCER CELLS BY AFFECTING ADHESION PROTEINS AND THE USES OF NEW COMPOUNDS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/541713 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24799 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004190.pdf [firstpage_image] =>[orig_patent_app_number] => 12541713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477847 [patent_doc_number] => 20100041621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 12/541504 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041621.pdf [firstpage_image] =>[orig_patent_app_number] => 12541504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938037 [patent_doc_number] => 20110213138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A HALOGENATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/539812 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 42820 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213138.pdf [firstpage_image] =>[orig_patent_app_number] => 12539812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6304379 [patent_doc_number] => 20100068728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'POLYSACCHARIDE DERIVATIVES AND USES IN INDUCTION OF AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/540249 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 28363 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068728.pdf [firstpage_image] =>[orig_patent_app_number] => 12540249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270515 [patent_doc_number] => 08212021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Process for making 5-azacytosine nucleosides and their derivatives' [patent_app_type] => utility [patent_app_number] => 12/538271 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4688 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12538271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304134 [patent_doc_number] => 20090298786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'METHODS OF TREATING VIRAL INFECTIONS WITH ANTHRACYCLINE ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 12/537270 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8839 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298786.pdf [firstpage_image] =>[orig_patent_app_number] => 12537270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6214774 [patent_doc_number] => 20110137022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHOD FOR THE ANALYSIS OF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/737771 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4292 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137022.pdf [firstpage_image] =>[orig_patent_app_number] => 12737771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340181 [patent_doc_number] => 08242106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Toll-like receptor agonist formulations and their use' [patent_app_type] => utility [patent_app_number] => 12/533596 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17757 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12533596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11656067 [patent_doc_number] => 09669050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity' [patent_app_type] => utility [patent_app_number] => 13/056805 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 7455 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571742 [patent_doc_number] => 08338387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Small molecule stimulators of neuronal growth' [patent_app_type] => utility [patent_app_number] => 12/511944 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 24467 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12511944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327066 [patent_doc_number] => 20100197621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/508494 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37570 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197621.pdf [firstpage_image] =>[orig_patent_app_number] => 12508494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283055 [patent_doc_number] => 08217156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use' [patent_app_type] => utility [patent_app_number] => 12/503225 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9009 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12503225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266607 [patent_doc_number] => 20100298265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin' [patent_app_type] => utility [patent_app_number] => 12/460236 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3023 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298265.pdf [firstpage_image] =>[orig_patent_app_number] => 12460236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628074 [patent_doc_number] => 20100004193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/497882 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6645 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004193.pdf [firstpage_image] =>[orig_patent_app_number] => 12497882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467045 [patent_doc_number] => 20100040594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'FORMULATIONS FOR NONSURGICAL EXOGENOUS CROSSLINK THERAPY' [patent_app_type] => utility [patent_app_number] => 12/496045 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22270 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040594.pdf [firstpage_image] =>[orig_patent_app_number] => 12496045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270442 [patent_doc_number] => 08211945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient' [patent_app_type] => utility [patent_app_number] => 12/490737 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 11922 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12490737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16460806 [patent_doc_number] => 10844141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Process for obtaining polysaccharides from jatoba ( [patent_app_type] => utility [patent_app_number] => 12/999816 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 4688 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146695 [patent_doc_number] => 08163716 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-04-24 [patent_title] => 'Method of administering hyaluronan formulation for the amelioration of osteophytes' [patent_app_type] => utility [patent_app_number] => 12/485265 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2246 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163716.pdf [firstpage_image] =>[orig_patent_app_number] => 12485265 [rel_patent_id] =>[rel_patent_doc_number] =>)